European Journal of Cancer
Volume 45, Issue 5 , Pages 851-856 , March 2009

Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age

  • Hedwig P. van de Nieuwenhof

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 24 3666455; fax: +31 24 3668597.
    • ,
  • Leon F.A.G. Massuger

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Irene A.M. van der Avoort

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Ruud L.M. Bekkers

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Mariel Casparie

      Affiliations

    • Foundation PALGA, Nationwide Netherlands Database of Histo- and Cytopathology, The Netherlands
    • ,
  • Wim Abma

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Léon C.L.T. van Kempen

      Affiliations

    • Department of Pathology, Radboud University Nijmegen Medical Centre, The Netherlands
    • ,
  • Joanne A. de Hullu

      Affiliations

    • Department of Obstetrics and Gynaecology (791), Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Received 2 September 2008 ,Revised 20 November 2008 ,Accepted 25 November 2008.

References 

  1. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):64–69
  2. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands. Utrecht: Hoonte–Holland BV; 1993;
  3. Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995;85(5 Pt 1):709–715
  4. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar oncology subcommittee. J Reprod Med. 2005;50(11):807–810
  5. van der Avoort I, Shirango H, Hoevenaars BM, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol. 2006;25(1):22–29
  6. Fox H, Wells M. Recent advances in the pathology of the vulva. Histopathology. 2003;42(3):209–216
  7. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27(1):125–135
  8. Roma AA, Hart WR. Progression of simplex (differentiated) vulvar intraepithelial neoplasia to invasive squamous cell carcinoma: a prospective case study confirming its precursor role in the pathogenesis of vulvar cancer. Int J Gynecol Pathol. 2007;26(3):248–253
  9. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24(3):429–441
  10. Hacker NF. Vulvar cancer. In:  Berek S,  Hacker NF editor. Practical gynaecologic oncology. 5th ed.. Philadelphia: Lippincott Williams and Wilkins; 2000;p. 553–596
  11. van Beurden M, ten Kate FJ, Smits HL, et al. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer. 1995;75(12):2879–2884
  12. Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006;108(6):1361–1368
  13. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol. 2005;106(6):1319–1326
  14. Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol. 1998;91(6):969–972
  15. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005;97(2):645–651
  16. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol. 1997;90(3):448–452
  17. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. 2000;45(8):613–615
  18. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107(5):1018–1022
  19. Menczer J, Barchana M, Andreev H, Rbel-Alon S, Modan B. Selected epidemiological time trends of vulvar carcinoma in Israel. Int J Gynecol Cancer. 1999;9(1):24–27
  20. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973–1987). Am J Obstet Gynecol. 1992;166(5):1482–1485
  21. Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol. 2002;84(1):94–101
  22. Losch A, Joura EA. Vulvar neoplasia in young women. Gynecol Oncol. 1999;75(3):519
  23. Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet Gynecol. 1995;86(1):51–54
  24. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29(1):19–24
  25. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med. 1999;340(10):745–750
  26. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. New Engl J Med. 2007;356(16):1670–1674
  27. van de Nieuwenhof HP, Massuger LF, de Hullu JA, et al. Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989–2003. Br J Cancer. 2008;98(1):165–167
  28. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol. 2001;20(1):16–30
  29. Hoevenaars BM, van der Avoort IAM, de Wilde PCM, et al. A panel of p16INK4A, MIB1 and p53 proteins can distinguish between the two pathways leading to vulvar squamous cell carcinoma. Int J Cancer. 2008;123(12):2767–2773
  30. Paraskevaidis E, Kalantaridou SN, Paschopoulos M, et al. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 2003;24(6):541–543
  31. Verguts J, Bronselaer B, Donders G, et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG. 2006;113(11):1303–1307

PII: S0959-8049(08)00958-1

doi: 10.1016/j.ejca.2008.11.037

European Journal of Cancer
Volume 45, Issue 5 , Pages 851-856 , March 2009

Article Tools

* Image Usage & Resolution